Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 4
2008 1
2011 2
2012 2
2013 1
2015 1
2017 1
2018 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Genomic and phylogenetic characterization of Elizabethkingia anophelis strains: The first two cases of life-threatening infection in Japan.
Ichiki K, Ooka T, Shinkawa T, Inoue S, Hayashida M, Nakamura D, Akimoto M, Yoshimitsu M, Kawamura H, Nakamura M, Obama Y, Gotoh Y, Hayashi T, Nishi J, Ishitsuka K. Ichiki K, et al. Among authors: akimoto m. J Infect Chemother. 2023 Apr;29(4):376-383. doi: 10.1016/j.jiac.2023.01.005. Epub 2023 Jan 20. J Infect Chemother. 2023. PMID: 36682607
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics.
Takahashi K, Setoguchi T, Tawaratsumida H, Arishima Y, Tominaga H, Ishidou Y, Nagano S, Shigemizu S, Aoki N, Akimoto M, Otsubo H, Matsuda T, Kakoi H, Izumi T, Nakamura S, Yokouchi M, Sunahara N, Komiya S. Takahashi K, et al. Among authors: akimoto m. BMC Musculoskelet Disord. 2015 Sep 30;16:269. doi: 10.1186/s12891-015-0732-x. BMC Musculoskelet Disord. 2015. PMID: 26420629 Free PMC article.
Association between Bone Mineral Density of Femoral Neck and Geriatric Nutritional Risk Index in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs.
Tokumoto H, Tominaga H, Arishima Y, Jokoji G, Akimoto M, Ohtsubo H, Taketomi E, Sunahara N, Nagano S, Ishidou Y, Komiya S, Setoguchi T. Tokumoto H, et al. Among authors: akimoto m. Nutrients. 2018 Feb 18;10(2):234. doi: 10.3390/nu10020234. Nutrients. 2018. PMID: 29463015 Free PMC article.
Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N. Kozako T, et al. Among authors: akimoto m. Hum Immunol. 2011 Nov;72(11):1001-6. doi: 10.1016/j.humimm.2011.07.308. Epub 2011 Aug 2. Hum Immunol. 2011. PMID: 21851845
Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T, Akimoto M, Toji S, White Y, Suzuki S, Arima T, Suruga Y, Matsushita K, Shimeno H, Soeda S, Kubota R, Izumo S, Uozumi K, Arima N. Kozako T, et al. Among authors: akimoto m. J Med Virol. 2011 Mar;83(3):501-9. doi: 10.1002/jmv.21985. J Med Virol. 2011. PMID: 21264872
17 results